PhRMA Offers “No Reasonable Expert” Standard For Addressing Fraud Charges

PhRMA is backing former InterMune CEO W. Scott Harkonen in his appeal of a fraud conviction for making false statements about Actimmune in a press release. The association argues that he expressed a scientific view that is protected from prosecution under the First Amendment.

More from Legal & IP

More from Pink Sheet